IBRN

IBRN
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
PRAX | Praxis Precision Medicines, Inc. | 5.61% | 803 | $270.41K |
AXSM | Axsome Therapeutics, Inc. | 4.53% | 1.33K | $218.63K |
BIIB | Biogen Inc. | 4.36% | 1.10K | $210.43K |
ALKS | Alkermes plc | 4.21% | 6.74K | $202.96K |
SUPN | Supernus Pharmaceuticals, Inc. | 4.12% | 3.59K | $199.92K |
XENE | Xenon Pharmaceuticals Inc. | 4.10% | 4.42K | $198.59K |
SRRK | Scholar Rock Holding Corporation | 4.09% | 4.42K | $198.28K |
DNLI | Denali Therapeutics Inc. | 3.78% | 8.59K | $182.02K |
ACAD | ACADIA Pharmaceuticals Inc. | 3.70% | 7.25K | $178.16K |
PTCT | PTC Therapeutics, Inc. | 3.64% | 2.58K | $175.66K |
CNTA | Centessa Pharmaceuticals plc | 3.52% | 6.32K | $169.84K |
ARGX | argenx SE | 3.52% | 221 | $169.49K |
NBIX | Neurocrine Biosciences, Inc. | 3.51% | 1.28K | $169.28K |
CPRX | Catalyst Pharmaceuticals, Inc. | 3.49% | 7.30K | $168.46K |
EWTX | Edgewise Therapeutics, Inc. | 3.17% | 5.03K | $153.02K |
DNTH | Dianthus Therapeutics, Inc. | 2.65% | 2.31K | $127.65K |
SRPT | Sarepta Therapeutics, Inc. | 2.34% | 6.51K | $113.53K |
DYN | Dyne Therapeutics, Inc. | 2.24% | 6.91K | $107.97K |
AXGN | AxoGen, Inc. | 1.95% | 2.96K | $93.95K |
BHVN | Biohaven Ltd. | 1.70% | 7.12K | $82.03K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
PRAX
Praxis Precision Medicines, Inc.
AXSM
Axsome Therapeutics, Inc.
BIIB
Biogen Inc.
ALKS
Alkermes plc
SUPN
Supernus Pharmaceuticals, Inc.
XENE
Xenon Pharmaceuticals Inc.
SRRK
Scholar Rock Holding Corporation
DNLI
Denali Therapeutics Inc.
ACAD
ACADIA Pharmaceuticals Inc.
PTCT
PTC Therapeutics, Inc.
CNTA
Centessa Pharmaceuticals plc
ARGX
argenx SE
NBIX
Neurocrine Biosciences, Inc.
CPRX
Catalyst Pharmaceuticals, Inc.
EWTX
Edgewise Therapeutics, Inc.
DNTH
Dianthus Therapeutics, Inc.
SRPT
Sarepta Therapeutics, Inc.
DYN
Dyne Therapeutics, Inc.
AXGN
AxoGen, Inc.
BHVN
Biohaven Ltd.
